LENZ

Lenz Therapeutics Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↑ 8/10
  • Momentum↓ 0/10
Lenz Therapeutics sales and earnings growth
LENZ Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 87.41%
  • FCF Y/Y↑ 35.53%
Lenz Therapeutics gross and profit margin trends
LENZ Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -336.50%
  • ROIC↓ -33.60%
Lenz Therapeutics net debt vs free cash flow
LENZ Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Lenz Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗